Stay updated on Venetoclax Combo vs Azacitidine in AML Clinical Trial
Sign up to get notified when there's something new on the Venetoclax Combo vs Azacitidine in AML Clinical Trial page.

Latest updates to the Venetoclax Combo vs Azacitidine in AML Clinical Trial page
- Check3 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3 (v3.4.2 removed).SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision: v3.4.2 deployed, replacing the previous v3.4.1. This update appears to be a version bump with no changes to clinical trial details.SummaryDifference0.0%

- Check32 days agoChange DetectedThe revision label on the page changed from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check33 days agoChange DetectedRevision: v3.4.1 is displayed, replacing Revision: v3.4.0.SummaryDifference0.0%

- Check40 days agoChange DetectedThe page includes minor UI and metadata updates: a 'Show glossary' option has been added; the 'Last Update Submitted' QC criteria label is now 'Last Update Submitted that Met QC Criteria'; capitalization for 'No FEAR Act Data' has been adjusted; and the revision version has been updated from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision: v3.3.4 is now displayed on the page, replacing the previous v3.3.3. This appears to be a minor system update with no changes to study information.SummaryDifference0.0%

Stay in the know with updates to Venetoclax Combo vs Azacitidine in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax Combo vs Azacitidine in AML Clinical Trial page.